BioStem Technologies, Inc. (BSEM)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. This filer's financial year end could not be read from its revenue history, so quarters are labelled by the calendar. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Quarterly

0 4M 8M 12M Q2 '25: 11M Q2 '26: 7.9M Q2 '25 Q2 '26

Gross Profit Quarterly

0 3.5M 7M 10.5M Q2 '25: 10.3M Q2 '26: 4.8M Q2 '25 Q2 '26

Operating Income Quarterly

-9M -6M -3M 0 3M 6M 9M Q2 '25: 112.8K Q2 '26: -8.4M Q2 '25 Q2 '26

Net Income Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q2 '25: 10.6K Q2 '26: -9M Q2 '25 Q2 '26

Cost of Revenue Quarterly

0 1.5M 3M 4.5M Q2 '25: 685.2K Q2 '26: 3.1M Q2 '25 Q2 '26

Operating Cash Flow Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Free Cash Flow Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 8M 16M 24M Q2 '25: 23.4M Q2 '26: 17.3M Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.